Kala Pharmaceuticals (NASDAQ:KALA) reported its Q4 earnings results on Tuesday, March 29, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Kala Pharmaceuticals missed estimated earnings by 65.85%, reporting an EPS of $-0.68 versus an estimate of $-0.41.
Revenue was down $382.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 2.86% increase in the share price the next day.
Here's a look at Kala Pharmaceuticals's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.43 | -0.45 | -0.68 | -0.46 |
| EPS Actual | -0.43 | -0.57 | -0.49 | -0.55 |
| Revenue Estimate | 5.16M | 5.33M | 4.18M | 2.39M |
| Revenue Actual | 3.07M | 3.05M | 3.27M | 2.24M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
